Frost & Sullivan

MARCH 22, 2024

Growing demand for outsourcing, with contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) leading industry growth. How are drug discovery companies enhancing R&D and accelerating growth through ecosystem partnerships?

Biopharma 52

Biopharma Ecosystems Biotech Contract research organization 52

Frost & Sullivan

FEBRUARY 15, 2024

Small- to mid-sized pharma/biotech players in APAC are rivaling Europe in clinical trials through multiple CRO partnerships in the region, tapping into a population-rich landscape. Let us coach you on your transformational journey, while we actively support you in fostering collaborative initiatives within your industry’s ecosystem.

Ecosystems 40

Ecosystems Contract research organization Biotech Utilities 40

Frost & Sullivan

MARCH 28, 2025

Innovating for Growth: The Future of Biotech CROs The biotech Contract Research Organization (CRO) industry is undergoing a rapid transformation, driven by technological advancements, globalization, and evolving patient needs. What are the top three trends you see driving change?

Biotech 52

Biotech Contract research organization Life science Strategic partnership 52

Frost & Sullivan

MAY 9, 2025

The Expanding Role of Clinical Contract Peripheral Services As the pharmaceutical and biopharma industries recalibrate after the COVID-19 pandemic, clinical trial outsourcing has surged, creating significant opportunities for contract research organizations (CROs). The global CRO industry, valued at $66.39

Mergers and acquisition activities 52

Mergers and acquisition activities Biopharma Biotechnology Biotech 52